Table 3B.
Clinical data of seven patients at second alloSCT.
| N | Donor 2nd Tx |
Cond 1st 2nd |
Int-dd 2nd Y/N |
Engr | GvHD grade | Alive 1 year Y/N |
Cause death |
|---|---|---|---|---|---|---|---|
| 1 | same | MEL | 42 | Y | III | N | GvHD |
| 2 | other | MEL | 39 | No | 0 | Y | – |
| 3 | other | Flu-CTX | 48 | Y | 0 | Y | – |
| 4 | other | MEL | 53 | Y | III | Y | – |
| 5 | same | MEL | 32 | Y | I | Y | – |
| 6 | other | MEL | 30 | No | 0 | N | Sepsis |
| 7 | other | MEL | 58 | Y | 0 | Y | – |
Donor 2nd Tx, donor of the second transplant; same, the same HAPLO donor as in the first transplant; other, other HAPLO family member; Int-dd 1st–2nd, interval in days between the first and second HAPLO transplants; Engr 2nd, engraftment after a second HAPLO Yes/NO; aGvHD, acute GvHD grade.